$IFF

Why is International Flavors & Fragrances stock up 4% today?

International Flavors & Fragrances (IFF) stock rose 4% to $88.37, near its 52-week high, driven by bullish analyst actions and a $2.5 billion share repurchase program. Argus raised its price target to $95, and the company's new vegan fragrance carrier also attracted investor interest. The broader market was mildly negative, making IFF's gain stock-specific. The company's next earnings report is expected around November 3.

Original reporting
Published Oct 13, 2026, 5:22 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 13, 2026, 5:35 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefMarket movers
Primary signal
$IFF
Bullish
medium confidence
Mentioned
$IFF
Relevance
5/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$IFFBullishMed
01

Why it matters

For traders, the key decision inputs are the buyback announcement, the analyst target raise to $95 from $85, and the proximity to the next earnings date, which can influence near-term positioning and volatility.

02

Market read

Stock-specific catalysts (buyback, analyst target raise, product momentum) are presented as the reason for today’s outperformance despite a slightly weaker broader market.

03

What to watch

Execution risk on the Food Ingredients divestiture and whether AQUASCENT adoption sustains margin expansion could cap upside before the Nov. 3 print.

Relevance 5/10Novelty 5/10Timing: mid-day today, ahead of the next earnings report expected around Nov. 3

Background

The piece frames IFF’s move as driven by analyst upgrades and a $2.5B repurchase program funded by proceeds from a planned Food Ingredients divestiture, alongside a new vegan water-based fragrance carrier launch.

Company-level read

Ticker impact

$IFFBullishMedium confidence
Context

IFF shares rose 4% as Argus raised its price target and the company announced a $2.5B buyback tied to a planned Food Ingredients divestiture.

Expected impact

Likely continued upside bias while traders price in buyback support and improving Scent segment traction ahead of the next earnings date.

Evidence & confidence

The article attributes the same-session move to analyst actions and the newly announced $2.5B repurchase program, both of which can drive incremental demand and sentiment into earnings.

Market effects

Supports sentiment for fragrance and consumer staples-adjacent names via a narrative of product innovation and capital returns.

Limited, as the article frames the move as stock-specific rather than index-driven.

Low, no cross-border policy or supply-chain shock is cited.

Counterpoint

The rally may be more sentiment and positioning than fundamentals, since the article relies on analyst actions and a planned divestiture rather than new earnings results.

Key entities

  • International Flavors & Fragrances

    IFF, the subject of the article, with a reported 4% intraday gain, a $2.5B share repurchase program, and a new AQUASCENT product launch.

  • Argus

    Raised its IFF price target to $95 from $85 and maintained a Buy rating on Oct. 7, cited as a momentum driver.

  • AQUASCENT

    IFF’s proprietary vegan, water-based fragrance carrier launched in late September, positioned as supporting higher fragrance loads than comparable systems.

Related articles

$IFFMed

India Opens Second Antitrust Investigation into Global Fragrance Giants

India's Competition Commission (CCI) is investigating Givaudan, dsm-firmenich, and International Flavors & Fragrances (IFF) for alleged price collusion in the fragrance industry, according to regulatory documents. The probe, separate from an ongoing anti-poaching case, was delayed after concerns over sensitive information. The companies face similar scrutiny in other markets and are cooperating. India's fragrance sector is expected to grow significantly.

$DARMedAI 8/10

A Look Back at Ingredients, Flavors & Fragrances Stocks’ Q2 Earnings: Darling Ingredients (NYSE:DAR) Vs The Rest Of The Pack

Ingredients, flavors, and fragrances stocks reported mixed Q2 earnings, with revenues missing estimates by 2.4%. Darling Ingredients (DAR) reported $1.72B revenue, up 16.4% YoY, beating estimates. Archer-Daniels-Midland (ADM) reported $22.68B revenue, up 7.2% YoY, outperforming estimates. International Flavors & Fragrances (IFF) reported $1.95B revenue, down 29.3% YoY, missing estimates. Ingredion (INGR) reported $1.85B revenue, flat YoY, topping estimates. Bunge Global (BG) reported $24.04B rev

$IFFMedAI 8/10

IFF (IFF) Q2 2026 Earnings Call Transcript

International Flavors & Fragrances (IFF) reported Q2 2026 revenue from continuing operations of $1.95 billion, up 6% currency-neutral, and adjusted EPS ex amortization of $0.82. Adjusted operating EBITDA was $408 million. The company plans a $4.3 billion Food Ingredients divestiture, $1B+ debt reduction, and a $2.5 billion share buyback. 2026 guidance: revenue $7.4B-$7.6B, EBITDA $1.53B-$1.60B.

$IFFMedAI 8/10

Read Analyst Questions From International Flavors & Fragrances’s Q2 Earnings Call

International Flavors & Fragrances (IFF) reported Q2 results driven by volume growth in Scent, Taste, and Health & Biosciences, with productivity improvements and margin discipline. Q2 revenue fell to $1.95B vs $2.61B estimates, and adjusted EPS was $0.82 vs $1.12. Full-year revenue guidance was cut to $7.5B midpoint from $10.65B. CEO said Food Ingredients divestiture is likely the last major portfolio change.

$IFFMedAI 8/10

International Flavors & Fragrances Q2 Earnings Call Highlights

International Flavors & Fragrances (IFF) reported Q2 segment results: Taste sales rose 4% to $688M, Health & Biosciences sales rose 5% to $601M, and Scent sales rose 8% to $665M. EBITDA increased across segments. IFF agreed to sell Food Ingredients to CVC for about $4.3B, and set 2026 guidance for $7.4B-$7.6B sales and $1.53B-$1.6B EBITDA.